Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Vocarzine vs Reagila (Cariprazine) in Healthy Subjects
NCT07121868Phase 1Completed
- Start
- Aug 2024
- Primary completion
- Jan 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of cariprazine in schizophrenia and bipolar disorder (BD) (2 arms). Primary endpoints: Area Under the Plasma Concentration-Time Curve from Time Zero to 72 Hours and Maximum Plasma Concentration. Started Aug 2024; status: completed.
02
Drugs
cariprazine
03
Conditions
schizophreniabipolar disorder (BD)
Beyond the preview
Go deeper on NCT07121868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07121868.